These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23121116)

  • 1. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
    Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A
    Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
    Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
    Bernstein JA; Relan A; Harper JR; Riedl M
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.
    Zuraw BL; Kalfus I
    Am J Med; 2012 Sep; 125(9):938.e1-7. PubMed ID: 22800873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
    Riedl MA; Grivcheva-Panovska V; Moldovan D; Baker J; Yang WH; Giannetti BM; Reshef A; Andrejevic S; Lockey RF; Hakl R; Kivity S; Harper JR; Relan A; Cicardi M
    Lancet; 2017 Sep; 390(10102):1595-1602. PubMed ID: 28754491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey.
    Farkas H; Zotter Z; Csuka D; Szabó E; Nébenfűhrer Z; Temesszentandrási G; Jakab L; Varga L; Harmat G; Karádi I
    Allergy; 2012 Dec; 67(12):1586-93. PubMed ID: 23025435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
    Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE
    BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
    Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
    Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
    Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
    van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
    J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.
    Varga L; Farkas H
    Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.
    Hack CE; Mannesse M; Baboeram A; Oortwijn B; Relan A
    BioDrugs; 2012 Oct; 26(5):303-13. PubMed ID: 22928662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
    Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
    Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.